Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: cmg who wrote (2094)	2/17/1998 11:06:00 AM
From: rl	Respond to of 3369

You and Gary have the essence of this latest transaction with SALV. If you look at the composition of the BOD, there is one British/Scottish national (also CEO), one Swiss, and one American (also a partner in the law firm that represents SALV). Since becoming the legal counsel of SALV it appears that SALV has spent close to $1 million on legal fees (can't be exact until 10K is filed, if then). You will have a difficult if not impossible task finding who owns Biscount, which is very probably some kind of Swiss shell/front used only as a Reg D or S investment vehicle. The SALV BOD probably doesn't even know anything about this group. Gary is absolutely right on in his analysis of this transaction. When the stock begins to be dumped, there is no way it can even sustain the current low price, reverse or no reverse. There is NO concern whatsoever for shareholders who have believed in the company. Why would a Brit, a Swiss, and a lawyer give a hoot about us?